drugset / Trial / NCT03927963

The Neuroprotection Effect of Dexmedetomidine

NCT03927963 ↗

RandomizedParallel-groupDouble-blindOther

Summary

The brain protection effect of dexmedetomidine has been approved in several studies. Basically, the anti-inflammatory effects and reducing catecholamines are thought to be a main role of the protection effect. In many studies reported the advantage of dexmedetomidine as a substitution of other sedative drugs for anesthesia. The anesthesia of intra-cranial aneurysmal clipping operation commonly use intravenous anesthetic agents combined with inhalation anesthesia for neuroprotection, and mostly propofol is used. The aim of this study is to examine the effects of dexmedetomidine on serum inflammatory markers and research the hemodynamic stability of dexmedetomidine compared to propofol in aneurysmal clipping operation.

Timeline

Start
2019-05-01
Primary completion
2020-09-30
Completion
2021-02-28

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dexmedetomidine Other / unclassified 0.7 ug/kg —
Comparator Propofol Small molecule 1.5 ng/ml —

Indications

No indication recorded.